HealthTech Voice Archived

Why can't a GLP-1 patient find which compounding pharmacy actually has tirzepatide in stock today?

After FDA shortage delisting in 2024 and 2025 compounding restrictions, semaglutide and tirzepatide patients ping many compounders a week by phone, and Hims, Ro, and Henry only push their captive pharmacy regardless of fill rate.

Who has it: Self-pay GLP-1 patient priced out of brand Wegovy or Zepbound.

9.3Score / 10

Severity9/10
Feasible today9/10
Market signal10/10
Competition gap9/10

What people report

Patients describe their compounder running out of tirzepatide again, then phoning pharmacy after pharmacy that are out or not taking new patients, and wishing for one place to check stock and price.

Our summary of a complaint that recurs in public posts, not a quote. Nobody submitted it to Real Problem AI.

Seen in: r/Semaglutide, r/Mounjaro, r/tirzepatidecompound recurring "who has stock" threads.

What nothing does yet

A voice agent that calls the long tail of state-licensed 503A compounding pharmacies daily, captures live stock and pricing for semaglutide and tirzepatide, and routes the patient with a transferable script.

Tools that solve this

3 named so far, and where each one stops.

Hims, Ro, Henry Meds
Captive pharmacy only, will not route elsewhere when their stock is out.
GoodRx
Brand drug pricing, does not cover compounders.
Mochi, Future Health
Tied to specific compounders.

Why it is archived

Retired in the 25 October 2026 freshness refresh: an older or overlapping problem replaced by a newer one people are discussing now.

How you might build it

01Voice agent calling 503A pharmacies
02State pharmacy board licensing database
03Script transfer workflow with prescriber
04Live stock and price feed

#H14 · Canonical URL: https://www.realproblem.ai/archive/why-cant-a-glp1-patient-find-which-compounder-actually-has-tirzepatide-in-stock-today